We demonstrate and discuss the testability of the common trend assumption imposed in Difference-in-Differences (DiD) estimation in panel data when not relying on multiple pre-treatment periods for running placebo tests. Our testing approach involves two steps: (i) constructing a control group of non-treated units whose pre-treatment outcome distribution matches that of treated units, and (ii) verifying if this control group and the original non-treated group share the same time trend in average outcomes. Testing is motivated by the fact that in several (but not all) panel data models, a common trend violation across treatment groups implies and is implied by a common trend violation across pre-treatment outcomes. For this reason, the test verifies a sufficient, but (depending on the model) not necessary condition for DiD-based identification. We investigate the finite sample performance of a testing procedure that is based on double machine learning, which permits controlling for covariates in a data-driven manner, in a simulation study and also apply it to labor market data from the National Supported Work Demonstration.
No takes yet. Share an insight, caveat, or question.
Martin Huber (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: